These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33098352)

  • 1. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment.
    Mezzana P
    Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
    Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
    BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted Impact of CO
    Jankovic S; Rovcanin M; Zamurovic M; Jovanovic B; Raicevic T; Tomic A
    Healthcare (Basel); 2024 Jul; 12(14):. PubMed ID: 39057528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
    Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
    Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.